EP224: Underestimate Employers at Your Peril, With Suzanne Delbanco, PhD, Executive Director of Catalyst for Payment Reform
Relentless Health Value™April 18, 2019
224
34:4247.65 MB

EP224: Underestimate Employers at Your Peril, With Suzanne Delbanco, PhD, Executive Director of Catalyst for Payment Reform

“Those who say it cannot be done are usually interrupted by others doing it.” That’s a James Baldwin quote to keep in mind while considering employers ginning up real change in the health care industry.

Generally speaking, employers who still don’t believe they could have an impact helping their employees get better health care at lower prices, don’t listen to this podcast. But if they did, I’d suggest this James Baldwin quote is apropos.

It’s probably also apropos for providers, carriers, Pharma … anyone who isn’t paying a whole lot of attention to the success of organizations like Catalyst for Payment Reform. Americans, meaning employees, can no longer afford their health care. Deductibles are higher than savings, basically meaning that employees have health plans they can’t even afford to use; and it costs as much as a midsize sedan—a new one every single year. Furthermore, we have employer health care spend chewing up raises. Employers and their CFOs are increasingly in a position where they have to act. It’s no longer an option.

I speak today with Suzanne Delbanco, PhD, executive director of Catalyst for Payment Reform. In one of her past lives, Suzanne was the founding CEO of The Leapfrog Group.

You can learn more at catalyze.org.

In addition, for a curriculum of podcasts to get you up to speed on what’s happening in the employer space, check out this blog post.

Suzanne Delbanco, PhD, is the executive director of Catalyst for Payment Reform (CPR), an independent, nonprofit corporation working to catalyze employers, public purchasers, and others to implement strategies that produce higher-value health care and improve the functioning of the health care marketplace. In addition to her duties at CPR, Suzanne serves on the advisory board of The Source on Healthcare Price & Competition at the University of California–Hastings and the Blue Cross Blue Shield Institute. Previously, she was the founding CEO of The Leapfrog Group. Suzanne holds a PhD in public policy from the Goldman School of Public Policy and an MPH from the School of Public Health at the University of California–Berkeley.  


02:25 The moment when Suzanne’s colleagues realized Leapfrog was needed.
03:58 Suzanne’s work at Catalyst for Payment Reform vs Leapfrog.
06:48 EP217 with Steve Watson—price points of hospitals and how the data evade us.
08:11 “At the end of the day, it’s very difficult to know if you’re getting good value if you don’t know what you’re paying.”
09:48 “The balance of power varies from market to market and has been changing over time.”
12:00 How employers can ban together to reduce their health care costs.
13:33 Price transparency.
16:04 Elevating the best practice.
16:51 A surprising contract point that everyone needs.
17:30 Getting rid of gag clauses.
19:26 “There’s never going to be 1 solution.”
19:38 Payment reform and what we mean by that.
20:42 Shared savings, shared risk, and bundled payments.
23:06 Today’s tipping point.
24:29 Trading choice for affordability.
26:43 Controlling costs 2 ways.
26:59 “Even if employers were … to … create a narrower network, not necessarily narrow, there’d be huge savings to be had.”
27:16 The limited sight of narrow networks.
27:36 Getting to a narrow network of high-quality, low-cost providers.
30:30 Suzanne’s advice for health care executives.
31:55 “Be prepared to demonstrate value, because employers [will] be asking.”

healthcare,reform,tech,catalyst for payment reform,employers,

Recent Episodes

EP445: Can a Primary-Care-Only Practice Survive in 2024? With Tom X. Lee, MD
July 25, 2024
445
47:5343.83 MB

EP445: Can a Primary-Care-Only Practice Survive in 2024? With Tom X. Lee, MD

In this healthcare podcast, I am talking with Tom X. Lee, MD, who has a long history in primary care. He founded One Medical and then also, most recently, Galileo. Dr. Lee also was a founder at Epocrates (tossing that in for context). For a full transcript of this episode, click here . If you enjoy...

Encore! EP397: The Minefield That Is a PBM Contract and Also Some Advice for EBCs Who Are Taking Money Under the Table, With Paul Holmes
July 18, 202434:1531.35 MB

Encore! EP397: The Minefield That Is a PBM Contract and Also Some Advice for EBCs Who Are Taking Money Under the Table, With Paul Holmes

Today is an encore because I am going on vacation next week. It always feels a little bit like a time warp because by the time this show will air, I will be back from vacation. This show with Paul Holmes was one of the most popular episodes of 2023 and definitely is just as relevant now. A lot of t...

EP444: Two State Healthcare Laws Often Don’t Go as Planned: CON and COPA, With Ann Kempski
July 11, 2024
444
35:1932.33 MB

EP444: Two State Healthcare Laws Often Don’t Go as Planned: CON and COPA, With Ann Kempski

Unintended consequences is a thing. ERCowboy wrote on Twitter a while back, “In any complex system, the likelihood of unintended consequences vastly outweighs the predictability of intended ones.” In this healthcare podcast, we’re talking about two state laws where this is apropos: CON (Certificate...

EP443: Let Us Never Pay the First Bill in Honor of Marshall Allen
July 04, 2024
443
36:1733.21 MB

EP443: Let Us Never Pay the First Bill in Honor of Marshall Allen

The first time I figuratively, not actually, met Marshall Allen was the day he did not meet Dave Chase for lunch. Dave was in Manhattan, and he was supposed to meet up with Marshall. But something happened, and Marshall was unable to make said lunch. So, I filled in for Marshall, who I had never me...

EP442: A Short Rumination on Saving Money, Except Not Saving Money. Oncology Side Effect Management as a Case Study, With Andreas Mang
June 27, 2024
442
18:5117.25 MB

EP442: A Short Rumination on Saving Money, Except Not Saving Money. Oncology Side Effect Management as a Case Study, With Andreas Mang

This week, I’m gonna play an outtake, I guess it could be called, from the show with Andreas Mang from Blackstone that we wound up cutting for reasons of time and topic; but it’s been on my mind ever since. So, here’s this clip; and then I’m gonna invite you to partake in my ruminations because the...

EP441: Tables Get Turned. This Is Me Interviewed by Abby Burns From Radio Advisory About What Is Value
June 20, 2024
441
40:3037.08 MB

EP441: Tables Get Turned. This Is Me Interviewed by Abby Burns From Radio Advisory About What Is Value

The show today is a recording of an earlier conversation between Abby Burns and myself. This original conversation happened during the Raising the Value Bar Summit, which was a summit all about value and the what, why, and how of it all. For a full transcript of this episode, click here . If you en...

EP440: What Is the Optimal Size for a Medical Practice? With David Muhlestein, PhD, JD
June 13, 2024
440
38:1535.01 MB

EP440: What Is the Optimal Size for a Medical Practice? With David Muhlestein, PhD, JD

Well, I reached out to David Muhlestein, PhD, JD, the other day to find out what he was up to since he left Leavitt Partners, which had been acquired by HMA, Health Management Associates. Answer: He’s building his own company in stealth mode. Stay tuned. For a full transcript of this episode, click...

Listen and Follow

Sponsored by Aventria Health Group
©2024 BD Bridges LLC. All Rights Reserved.